argenx Share Price (ARGX.BR)

argenx is listed in the Medicine and Biotech sector.

Argenx Se is listed on the Euronext Brussels trading with ticker code ARGX.BR. It has a market capitalisation of €48.12b, with approximately 62.19m shares in issue. Over the last year, argenx share price has been traded in a range of 353.40, hitting a high of 810.00, and a low of 456.60. It is classified as being part of the Biotechnology subsector.

argenx SE is a biopharmaceutical company headquartered in Belgium, specialising in the discovery and development of innovative antibody-based therapies for severe autoimmune diseases and cancer. Leveraging its proprietary antibody platform, the company aims to address unmet medical needs and improve patient outcomes. argenx's pipeline includes promising candidates targeting various diseases, including myasthenia gravis and acute myeloid leukemia. Committed to scientific excellence and patient-centric innovation, argenx collaborates with leading researchers and institutions to advance its therapeutic programs. With a focus on transformative treatments, the company continues to make significant strides in the field of biotechnology.